| (+)-pilocarpine | decreases expression | ISO | RGD:628734 | 6480464 | Pilocarpine results in decreased expression of TNFSF10 mRNA | CTD | PMID:17971868 |
| (-)-epigallocatechin 3-gallate | decreases expression | EXP | | 6480464 | epigallocatechin gallate results in decreased expression of TNFSF10 mRNA | CTD | PMID:16084531 |
| (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TNFSF10 mRNA | CTD | PMID:22079256 |
| (R)-mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; more ... | CTD | PMID:21910007 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of TNFSF10 mRNA | CTD | PMID:20106945 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of TNFSF10 mRNA | CTD | PMID:20106945 PMID:23373633 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of TNFSF10 mRNA | CTD | PMID:19619570 PMID:21185374 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of TNFSF10 mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TNFSF10 mRNA | CTD | PMID:19619570 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | affects expression | EXP | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl affects the expression of TNFSF10 mRNA | CTD | PMID:20638727 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TNFSF10 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:732827 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFSF10 mRNA | CTD | PMID:12167310 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of TNFSF10 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:732827 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFSF10 mRNA | CTD | PMID:15310856 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:732827 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFSF10 mRNA | CTD | PMID:12167310 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:732827 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFSF10 mRNA | CTD | PMID:15310856 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TNFSF10 mRNA | CTD | PMID:11007951 PMID:11489354 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:732827 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFSF10 mRNA | CTD | PMID:14718643 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:628734 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TNFSF10 mRNA | CTD | PMID:19520675 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:732827 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFSF10 mRNA | CTD | PMID:14718643 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TNFSF10 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TNFSF10 mRNA | CTD | PMID:11489354 PMID:11007951 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TNFSF10 mRNA] | CTD | PMID:11007951 |
| 2,3-dimethoxynaphthalene-1,4-dione | decreases expression | EXP | | 6480464 | 2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of TNFSF10 mRNA | CTD | PMID:17547211 |
| 2,4,6-trinitrotoluene | affects expression | ISO | RGD:628734 | 6480464 | Trinitrotoluene affects the expression of TNFSF10 mRNA | CTD | PMID:21346803 |
| 2-trans,6-trans,10-trans-geranylgeranyl diphosphate | multiple interactions | EXP | | 6480464 | geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; more ... | CTD | PMID:21910007 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:732827 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of TNFSF10 mRNA | CTD | PMID:18648102 |
| 4-hydroxyphenyl retinamide | multiple interactions | EXP | | 6480464 | [Fenretinide co-treated with TNFSF10 protein] results in increased activity of CASP10 protein; more ... | CTD | PMID:17273769 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | AKT1 protein inhibits the reaction [decitabine results in increased expression of TNFSF10 protein]; more ... | CTD | PMID:17283156 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[Valproic Acid co-treated with decitabine] results in increased susceptibility to TNFSF10 protein]; more ... | CTD | PMID:21771726 |
| 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | decitabine results in increased expression of TNFSF10 mRNA; more ... | CTD | PMID:17283156 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | [decitabine co-treated with TNFSF10 protein] results in increased activity of CASP8 protein; more ... | CTD | PMID:18636160 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | [[[decitabine co-treated with IFNG protein] results in increased expression of CASP8 protein] which co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | CTD | PMID:16607283 |
| 5-azacytidine | increases response to substance | EXP | | 6480464 | Azacitidine results in increased susceptibility to TNFSF10 protein | CTD | PMID:18829727 |
| 5-azacytidine | increases response to substance | ISO | RGD:732827 | 6480464 | Azacitidine results in increased susceptibility to TNFSF10 protein | CTD | PMID:18829727 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | CFLAR protein inhibits the reaction [Fluorouracil results in increased susceptibility to TNFSF10 protein]; more ... | CTD | PMID:20876774 |
| 5-fluorouracil | increases expression | ISO | RGD:732827 | 6480464 | Fluorouracil results in increased expression of TNFSF10 protein | CTD | PMID:19106633 |
| 5-fluorouracil | increases activity | EXP | | 6480464 | Fluorouracil results in increased activity of TNFSF10 protein | CTD | PMID:16373718 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | TP53 protein promotes the reaction [Fluorouracil results in increased expression of TNFSF10 mRNA]; more ... | CTD | PMID:19106633 |
| 5-fluorouracil | increases response to substance | EXP | | 6480464 | Fluorouracil results in increased susceptibility to TNFSF10 protein | CTD | PMID:20876774 |
| 5-fluorouracil | increases abundance | EXP | | 6480464 | TNFSF10 results in increased abundance of Fluorouracil | CTD | PMID:11750847 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of TNFSF10 mRNA; more ... | CTD | PMID:19106633 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | [Fluorouracil co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein | CTD | PMID:15120327 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | CFLAR protein alternative form inhibits the reaction [Fluorouracil results in increased activity of TNFSF10 protein] | CTD | PMID:16373718 |
| 8'-apo-beta,psi-caroten-8'-al | increases expression | EXP | | 6480464 | apocarotenal results in increased expression of TNFSF10 mRNA | CTD | PMID:17034753 |
| 9-cis-retinoic acid | increases expression | EXP | | 6480464 | alitretinoin results in increased expression of TNFSF10 mRNA; more ... | CTD | PMID:16449964 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | [Aspirin co-treated with TNFSF10 protein] results in decreased expression of BIRC5 protein; more ... | CTD | PMID:18483385 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:628734 | 6480464 | Aspirin inhibits the reaction [Azoxymethane results in increased expression of TNFSF10 mRNA] | CTD | PMID:20043115 |
| acetylsalicylic acid | increases response to substance | EXP | | 6480464 | Aspirin results in increased susceptibility to TNFSF10 protein | CTD | PMID:21171083 PMID:18483385 |
| acetylsalicylic acid | increases response to substance | EXP | | 6480464 | Aspirin results in increased susceptibility to TNFSF10 protein | CTD | PMID:18483385 PMID:21171083 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:16199534 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | [Aspirin co-treated with TNFSF10 protein] results in increased activity of CASP8 protein; more ... | CTD | PMID:21171083 |
| actinomycin D | multiple interactions | EXP | | 6480464 | [Dactinomycin co-treated with TNFSF10 protein] results in increased activity of CASP7 protein; more ... | CTD | PMID:17707539 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | TGFB1 protein inhibits the reaction [Tretinoin results in increased expression of TNFSF10 protein] | CTD | PMID:16242776 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of TNFSF10 mRNA | CTD | PMID:16140955 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of TNFSF10 protein | CTD | PMID:16242776 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin promotes the reaction [IFNG protein promotes the reaction [IRF1 protein results in increased expression of TNFSF10 mRNA]]; more ... | CTD | PMID:16085646 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Thiophenes analog promotes the reaction [Tretinoin results in increased expression of TNFSF10 mRNA] | CTD | PMID:16140955 |
| aluminium oxide | increases expression | EXP | | 6480464 | Aluminum Oxide analog results in increased expression of TNFSF10 mRNA | CTD | PMID:23132795 |
| amiloride | multiple interactions | EXP | | 6480464 | Amiloride promotes the reaction [TNFSF10 protein affects the localization of CYCS protein]; more ... | CTD | PMID:15607733 |
| amiloride | multiple interactions | EXP | | 6480464 | Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | CTD | PMID:16059913 PMID:15607733 |
| amiloride | multiple interactions | EXP | | 6480464 | Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | CTD | PMID:15607733 PMID:16059913 |
| amiloride | multiple interactions | EXP | | 6480464 | Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein]; more ... | CTD | PMID:16059913 |
| amiodarone | increases response to substance | EXP | | 6480464 | Amiodarone results in increased susceptibility to TNFSF10 protein | CTD | PMID:21292685 |
| amiodarone | multiple interactions | EXP | | 6480464 | [TNFSF10 co-treated with Amiodarone] results in increased cleavage of BID protein; more ... | CTD | PMID:21292685 |
| ammonium chloride | affects expression | ISO | RGD:628734 | 6480464 | Ammonium Chloride affects the expression of TNFSF10 mRNA | CTD | PMID:16483693 |
| antimony(0) | decreases expression | EXP | | 6480464 | Antimony results in decreased expression of TNFSF10 mRNA | CTD | PMID:17547211 |
| Aroclor 1254 | decreases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of TNFSF10 mRNA | CTD | PMID:17851650 PMID:16934159 |
| Aroclor 1254 | decreases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of TNFSF10 mRNA | CTD | PMID:16934159 PMID:17851650 |
| arsenic atom | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of TNFSF10 mRNA | CTD | PMID:19962721 |
| arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of TNFSF10 mRNA | CTD | PMID:11134558 |
| arsenic atom | multiple interactions | EXP | | 6480464 | [Arsenic co-treated with Fluorides] results in decreased expression of TNFSF10 mRNA | CTD | PMID:19962721 |
| benzo[a]pyrene | decreases expression | ISO | RGD:732827 | 6480464 | Benzo(a)pyrene results in decreased expression of TNFSF10 mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | increases activity | EXP | | 6480464 | Benzo(a)pyrene results in increased activity of TNFSF10 protein | CTD | PMID:22951985 |
| benzo[a]pyrene | increases expression | ISO | RGD:732827 | 6480464 | Benzo(a)pyrene results in increased expression of TNFSF10 mRNA | CTD | PMID:22610609 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | AHR mutant form inhibits the reaction [[Benzo(a)pyrene co-treated with TNFSF10 protein] results in increased cleavage of CASP8 protein]; more ... | CTD | PMID:22951985 |
| bepridil | increases response to substance | EXP | | 6480464 | Bepridil results in increased susceptibility to TNFSF10 protein | CTD | PMID:21292685 |
| beta-carotene | increases expression | EXP | | 6480464 | beta Carotene results in increased expression of TNFSF10 mRNA | CTD | PMID:17034753 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:732827 | 6480464 | Mustard Gas results in increased expression of TNFSF10 mRNA | CTD | PMID:15674843 |
| brefeldin A | multiple interactions | EXP | | 6480464 | Brefeldin A affects the reaction [bortezomib results in increased susceptibility to and results in increased activity of TNFSF10 protein] | CTD | PMID:17326159 |
| cadmium atom | decreases expression | EXP | | 6480464 | Cadmium results in decreased expression of TNFSF10 mRNA | CTD | PMID:17547211 |
| cadmium atom | increases response to substance | ISO | RGD:732827 | 6480464 | TNFSF10 results in increased susceptibility to Cadmium | CTD | PMID:12189181 |
| cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of TNFSF10 mRNA | CTD | PMID:17547211 |
| cadmium dichloride | decreases expression | ISO | RGD:732827 | 6480464 | Cadmium Chloride results in decreased expression of TNFSF10 mRNA | CTD | PMID:15501611 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFSF10 mRNA | CTD | PMID:12634122 |
| capsaicin | multiple interactions | EXP | | 6480464 | BIRC5 results in decreased activity of [Capsaicin co-treated with TNFSF10 protein]; more ... | CTD | PMID:19939880 |
| capsaicin | multiple interactions | EXP | | 6480464 | Capsaicin promotes the reaction [SP1 protein binds to TNFSF10 promoter]; more ... | CTD | PMID:22200406 |
| capsaicin | increases activity | EXP | | 6480464 | Capsaicin results in increased activity of TNFSF10 protein | CTD | PMID:22200406 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of TNFSF10 mRNA; more ... | CTD | PMID:22200406 |
| capsaicin | increases response to substance | EXP | | 6480464 | Capsaicin results in increased susceptibility to TNFSF10 protein | CTD | PMID:19939880 |
| capsaicin | increases expression | ISO | RGD:628734 | 6480464 | Capsaicin results in increased expression of TNFSF10 protein | CTD | PMID:22150557 |
| capsaicin | multiple interactions | ISO | RGD:628734 | 6480464 | Naproxen inhibits the reaction [Capsaicin results in increased expression of TNFSF10 protein]; more ... | CTD | PMID:22150557 |
| carmustine | affects response to substance | EXP | | 6480464 | TNFSF10 mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 |
| celastrol | multiple interactions | EXP | | 6480464 | [TNFSF10 protein co-treated with tripterine] results in increased cleavage of CASP3 protein; more ... | CTD | PMID:20605676 |
| celastrol | increases response to substance | EXP | | 6480464 | tripterine results in increased susceptibility to TNFSF10 protein | CTD | PMID:20605676 |
| celecoxib | multiple interactions | EXP | | 6480464 | TNFSF10 protein promotes the reaction [celecoxib results in increased cleavage of and results in increased activity of CASP3 protein]; more ... | CTD | PMID:15572759 |
| chloroprene | decreases expression | ISO | RGD:732827 | 6480464 | Chloroprene results in decreased expression of TNFSF10 mRNA | CTD | PMID:23125180 |
| chlorpyrifos | increases expression | ISO | RGD:732827 | 6480464 | Chlorpyrifos results in increased expression of TNFSF10 mRNA | CTD | PMID:22515965 |
| cholesterol | increases expression | ISO | RGD:628734 | 6480464 | Cholesterol analog results in increased expression of TNFSF10 mRNA; more ... | CTD | PMID:19477266 |
| chromium atom | decreases expression | EXP | | 6480464 | Chromium results in decreased expression of TNFSF10 mRNA | CTD | PMID:17547211 |
| chrysazin | increases expression | EXP | | 6480464 | danthron results in increased expression of TNFSF10 protein | CTD | PMID:21126053 |
| cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with LBH589] affects the expression of TNFSF10 mRNA; more ... | CTD | PMID:21791302 |
| cisplatin | increases response to substance | EXP | | 6480464 | Cisplatin results in increased susceptibility to TNFSF10 protein | CTD | PMID:20856198 more ... |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP3 protein] | CTD | PMID:21037225 PMID:20856198 |
| cisplatin | increases response to substance | EXP | | 6480464 | Cisplatin results in increased susceptibility to TNFSF10 protein | CTD | PMID:20876774 more ... |
| cisplatin | affects response to substance | EXP | | 6480464 | TNFSF10 protein affects the susceptibility to Cisplatin | CTD | PMID:16638878 PMID:16217747 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of TNFSF10 mRNA | CTD | PMID:21801448 PMID:20623264 |
| cisplatin | multiple interactions | EXP | | 6480464 | TNFSF10 protein promotes the reaction [Cisplatin results in increased cleavage of and results in increased activity of CASP3 protein]; more ... | CTD | PMID:20623264 |
| cisplatin | increases response to substance | EXP | | 6480464 | Cisplatin results in increased susceptibility to TNFSF10 protein | CTD | PMID:20856198 more ... |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of TNFSF10 protein | CTD | PMID:20623264 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of TNFSF10 mRNA | CTD | PMID:20623264 PMID:21801448 |
| cisplatin | multiple interactions | EXP | | 6480464 | [TNFSF10 protein co-treated with Cisplatin] results in decreased expression of BCL2L1 protein; more ... | CTD | PMID:21252285 |
| cisplatin | affects response to substance | EXP | | 6480464 | TNFSF10 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 PMID:16638878 |
| cisplatin | multiple interactions | EXP | | 6480464 | TNFRSF10B protein promotes the reaction [Cisplatin results in increased susceptibility to TNFSF10 protein]; more ... | CTD | PMID:21152876 |
| cisplatin | increases uptake | EXP | | 6480464 | Cisplatin results in increased uptake of TNFSF10 protein | CTD | PMID:21037225 |
| cisplatin | increases response to substance | EXP | | 6480464 | Cisplatin results in increased susceptibility to TNFSF10 protein | CTD | PMID:21152876 more ... |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of TNFSF10 mRNA | CTD | PMID:21801448 |
| cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin results in increased expression of CASP8 protein] which results in increased susceptibility to TNFSF10 protein | CTD | PMID:21487429 |
| cisplatin | increases activity | EXP | | 6480464 | Cisplatin results in increased activity of TNFSF10 protein | CTD | PMID:16638878 |
| cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin results in decreased expression of CFLAR protein] which results in increased susceptibility to TNFSF10 protein | CTD | PMID:20876774 |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein] | CTD | PMID:21037225 |
| cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP3 protein]] which results in increased cleavage of XIAP protein | CTD | PMID:20856198 |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP3 protein] | CTD | PMID:20856198 PMID:21037225 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of TNFSF10 mRNA | CTD | PMID:19549813 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of TNFSF10 mRNA | CTD | PMID:16101141 PMID:15713895 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of TNFSF10 mRNA | CTD | PMID:15713895 PMID:16101141 |
| curcumin | multiple interactions | EXP | | 6480464 | TNFSF10 protein promotes the reaction [Curcumin results in decreased activity of RELA protein]; more ... | CTD | PMID:18226269 |
| cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TNFSF10 mRNA] | CTD | PMID:11007951 |
| cycloheximide | multiple interactions | EXP | | 6480464 | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Cycloheximide co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein]; more ... | CTD | PMID:18222423 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of TNFSF10 mRNA | CTD | PMID:20106945 |
| cyclosporin A | multiple interactions | EXP | | 6480464 | Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] | CTD | PMID:21603612 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of TNFSF10 mRNA | CTD | PMID:22147139 |
| cytarabine | multiple interactions | EXP | | 6480464 | [Cytarabine co-treated with TNFSF10 protein] results in increased activity of CASP8 protein; more ... | CTD | PMID:12780785 |
| cytarabine | increases expression | EXP | | 6480464 | Cytarabine results in increased expression of TNFSF10 mRNA | CTD | PMID:19194470 |
| cytarabine | multiple interactions | EXP | | 6480464 | Cytarabine promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein]; more ... | CTD | PMID:18549619 |
| dacarbazine | multiple interactions | EXP | | 6480464 | TNFSF10 protein promotes the reaction [Dacarbazine results in increased cleavage of and results in increased activity of CASP3 protein]; more ... | CTD | PMID:17410615 |
| daunorubicin | multiple interactions | EXP | | 6480464 | [Daunorubicin co-treated with TNFSF10 protein] results in increased activity of CASP8 protein; more ... | CTD | PMID:12780785 |
| daunorubicin | multiple interactions | EXP | | 6480464 | Daunorubicin promotes the reaction [TNFSF10 results in increased expression of TNFRSF10A mRNA]; more ... | CTD | PMID:17204177 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [TNFSF10 protein results in increased activity of CASP3 protein]; more ... | CTD | PMID:17070682 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | CTD | PMID:16144937 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | [arsenic trioxide co-treated with bortezomib] results in increased expression of TNFSF10 mRNA | CTD | PMID:20471514 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | arsenic trioxide promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein]; more ... | CTD | PMID:16434995 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of TNFSF10 mRNA | CTD | PMID:17530438 more ... |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of TNFSF10 mRNA | CTD | PMID:17530438 PMID:20458559 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | TP53 protein affects the reaction [arsenic trioxide results in increased expression of TNFSF10 protein] | CTD | PMID:12851490 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | DDIT3 results in increased susceptibility to [arsenic trioxide co-treated with TNFSF10] | CTD | PMID:18172319 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of TNFSF10 protein | CTD | PMID:12851490 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of TNFSF10 mRNA | CTD | PMID:20953137 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of TNFSF10 mRNA | CTD | PMID:20458559 PMID:17530438 |
| dichromium trioxide | multiple interactions | EXP | | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFSF10 mRNA | CTD | PMID:12634122 |
| diethylstilbestrol | increases expression | ISO | RGD:732827 | 6480464 | Diethylstilbestrol results in increased expression of TNFSF10 mRNA | CTD | PMID:15545218 |
| dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | decreases expression | EXP | | 6480464 | Antimony Potassium Tartrate results in decreased expression of TNFSF10 mRNA | CTD | PMID:17547211 |
| disodium selenite | decreases expression | EXP | | 6480464 | Sodium Selenite results in decreased expression of TNFSF10 mRNA | CTD | PMID:16705456 |
| docetaxel anhydrous | multiple interactions | EXP | | 6480464 | docetaxel promotes the reaction [TNFSF10 results in increased cleavage of PARP1 protein] | CTD | PMID:18404675 |
| dopamine | decreases expression | ISO | RGD:628734 | 6480464 | Dopamine results in decreased expression of TNFSF10 mRNA | CTD | PMID:21983523 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of TNFSF10 protein; more ... | CTD | PMID:19106633 |
| doxorubicin | increases secretion | ISO | RGD:628734 | 6480464 | Doxorubicin results in increased secretion of TNFSF10 protein | CTD | PMID:15703961 |
| doxorubicin | multiple interactions | ISO | RGD:732827 | 6480464 | [Doxorubicin results in increased activity of SMPD1 protein] promotes the reaction [TNFSF10 protein binds to TNFSF10 protein] | CTD | PMID:17520194 |
| doxorubicin | multiple interactions | EXP | | 6480464 | TNFSF10 protein promotes the reaction [Doxorubicin results in increased activity of CASP3 protein]; more ... | CTD | PMID:19106633 |
| doxorubicin | affects response to substance | EXP | | 6480464 | TNFSF10 affects the susceptibility to Doxorubicin | CTD | PMID:17283156 |
| doxorubicin | affects response to substance | EXP | | 6480464 | TNFSF10 protein affects the susceptibility to Doxorubicin | CTD | PMID:19106633 |
| elemental selenium | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of TNFSF10 mRNA | CTD | PMID:19244175 |
| ethanol | decreases expression | ISO | RGD:732827 | 6480464 | Ethanol results in decreased expression of TNFSF10 protein | CTD | PMID:18166357 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | EXP | | 6480464 | Egtazic Acid inhibits the reaction [Capsaicin results in increased expression of TNFSF10 mRNA] | CTD | PMID:22200406 |
| fenoldopam | decreases expression | ISO | RGD:628734 | 6480464 | Fenoldopam results in decreased expression of TNFSF10 mRNA | CTD | PMID:21983523 |
| fumonisin B1 | increases expression | ISO | RGD:732827 | 6480464 | fumonisin B1 results in increased expression of TNFSF10 mRNA | CTD | PMID:15590129 |
| furosemide | affects expression | ISO | RGD:628734 | 6480464 | Furosemide affects the expression of TNFSF10 mRNA | CTD | PMID:17497460 |
| gadolinium trichloride | increases expression | ISO | RGD:732827 | 6480464 | gadolinium chloride results in increased expression of TNFSF10 mRNA | CTD | PMID:15590129 |
| genistein | multiple interactions | EXP | | 6480464 | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone results in decreased susceptibility to [Genistein co-treated with TNFSF10 protein]; more ... | CTD | PMID:19497411 |
| genistein | decreases expression | ISO | RGD:732827 | 6480464 | Genistein results in decreased expression of TNFSF10 mRNA | CTD | PMID:16169203 |
| genistein | increases response to substance | EXP | | 6480464 | Genistein results in increased susceptibility to TNFSF10 protein | CTD | PMID:19497411 |
| iron atom | increases expression | EXP | | 6480464 | Iron deficiency results in increased expression of TNFSF10 mRNA | CTD | PMID:20368581 |
| isoflurane | decreases expression | ISO | RGD:628734 | 6480464 | Isoflurane results in decreased expression of TNFSF10 mRNA | CTD | PMID:16978161 |
| isotretinoin | increases expression | EXP | | 6480464 | Isotretinoin results in increased expression of TNFSF10 mRNA | CTD | PMID:18769122 |
| kojic acid | multiple interactions | ISO | RGD:628734 | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TNFSF10 mRNA | CTD | PMID:18544905 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with Ascorbic Acid] results in decreased expression of TNFSF10 mRNA | CTD | PMID:17639512 |
| lead diacetate | multiple interactions | EXP | | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFSF10 mRNA | CTD | PMID:12634122 |
| lead diacetate | increases expression | ISO | RGD:732827 | 6480464 | lead acetate results in increased expression of TNFSF10 mRNA | CTD | PMID:20542052 |
| lovastatin | increases response to substance | EXP | | 6480464 | Lovastatin results in increased susceptibility to TNFSF10 protein | CTD | PMID:17928957 |
| luteolin | multiple interactions | EXP | | 6480464 | Luteolin promotes the reaction [TNFSF10 protein results in increased activity of CASP3 protein]; more ... | CTD | PMID:16140950 |
| LY294002 | multiple interactions | EXP | | 6480464 | [TNFSF10 protein co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in increased cleavage of CASP3 protein; more ... | CTD | PMID:19261616 |
| LY294002 | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TNFSF10 protein] | CTD | PMID:21179458 |
| LY294002 | multiple interactions | EXP | | 6480464 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with TNFSF10 protein] results in increased activity of BAX protein | CTD | PMID:20097879 |
| LY294002 | increases expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TNFSF10 protein | CTD | PMID:21179458 |
| mercury atom | decreases expression | EXP | | 6480464 | Mercury results in decreased expression of TNFSF10 mRNA | CTD | PMID:17547211 |
| mercury(0) | decreases expression | EXP | | 6480464 | Mercury results in decreased expression of TNFSF10 mRNA | CTD | PMID:17547211 |
| mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; more ... | CTD | PMID:21910007 |
| mifepristone | multiple interactions | EXP | | 6480464 | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [TNFSF10 protein results in increased activity of CASP3 protein]]; more ... | CTD | PMID:17070682 |
| mithramycin | multiple interactions | EXP | | 6480464 | [Plicamycin inhibits the reaction [SP1 protein binds to TNFSF10 promoter]] which results in increased expression of TNFSF10 protein | CTD | PMID:21603612 PMID:21603612 |
| mithramycin | multiple interactions | EXP | | 6480464 | Plicamycin inhibits the reaction [SP1 protein binds to TNFSF10 promoter] | CTD | PMID:21603612 |
| mitomycin C | multiple interactions | EXP | | 6480464 | [Mitomycin co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein | CTD | PMID:15120327 |
| monocrotaline | multiple interactions | ISO | RGD:732827 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of TNFSF10 mRNA | CTD | PMID:21224054 |
| morphine | increases expression | ISO | RGD:732827 | 6480464 | Morphine results in increased expression of TNFSF10 mRNA | CTD | PMID:16210602 |
| N,N-dimethylformamide | increases expression | EXP | | 6480464 | Dimethylformamide results in increased expression of TNFSF10 mRNA; more ... | CTD | PMID:18063697 |
| N-acetyl-L-cysteine | decreases expression | EXP | | 6480464 | Acetylcysteine results in decreased expression of TNFSF10 mRNA | CTD | PMID:16084531 |
| N-acetyl-L-cysteine | decreases response to substance | EXP | | 6480464 | Acetylcysteine results in decreased susceptibility to TNFSF10 protein | CTD | PMID:20971099 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased abundance of Reactive Oxygen Species]; more ... | CTD | PMID:20971099 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:732827 | 6480464 | [dicyclanil co-treated with Diethylnitrosamine] results in decreased expression of TNFSF10 mRNA | CTD | PMID:17162532 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:628734 | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TNFSF10 mRNA | CTD | PMID:18544905 |
| N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of TNFSF10 protein | CTD | PMID:17849272 |
| naproxen | multiple interactions | ISO | RGD:628734 | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of TNFSF10 protein]; more ... | CTD | PMID:22150557 |
| nickel dichloride | decreases expression | EXP | | 6480464 | nickel chloride results in decreased expression of TNFSF10 mRNA | CTD | PMID:17547211 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of TNFSF10 mRNA | CTD | PMID:17312168 |
| nickel sulfate | decreases expression | EXP | | 6480464 | nickel sulfate results in decreased expression of TNFSF10 mRNA | CTD | PMID:18651567 |
| nordihydroguaiaretic acid | multiple interactions | EXP | | 6480464 | [Nordihydroguaiaretic Acid co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of BID protein; more ... | CTD | PMID:17645780 |
| NS-398 | multiple interactions | EXP | | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [sodium arsenite results in increased expression of and results in increased localization of TNFRSF10B protein]] results in increased susceptibility to [TNFSF10 protein co-treated with Cycloheximide]; more ... | CTD | PMID:18222423 |
| okadaic acid | multiple interactions | EXP | | 6480464 | Okadaic Acid inhibits the reaction [Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]] | CTD | PMID:16059913 |
| oxaliplatin | increases activity | EXP | | 6480464 | oxaliplatin results in increased activity of TNFSF10 protein | CTD | PMID:16373718 |
| oxaliplatin | multiple interactions | EXP | | 6480464 | CFLAR protein alternative form inhibits the reaction [oxaliplatin results in increased activity of TNFSF10 protein] | CTD | PMID:16373718 |
| ozone | decreases expression | ISO | RGD:732827 | 6480464 | Ozone results in decreased expression of TNFSF10 mRNA | CTD | PMID:17095637 |
| paclitaxel | increases expression | EXP | | 6480464 | Paclitaxel results in increased expression of TNFSF10 protein | CTD | PMID:15907983 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of TNFSF10 mRNA | CTD | PMID:21420995 |
| paraquat | increases expression | ISO | RGD:732827 | 6480464 | Paraquat results in increased expression of TNFSF10 mRNA | CTD | PMID:22938100 |
| phenobarbital | increases expression | ISO | RGD:732827 | 6480464 | Phenobarbital results in increased expression of TNFSF10 mRNA | CTD | PMID:19270015 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of TNFSF10 mRNA | CTD | PMID:19159669 |
| phenytoin | multiple interactions | ISO | RGD:732827 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of TNFSF10 mRNA | CTD | PMID:21224054 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | NFATC1 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; more ... | CTD | PMID:21603612 |
| potassium dichromate | decreases expression | EXP | | 6480464 | Potassium Dichromate results in decreased expression of TNFSF10 mRNA | CTD | PMID:17547211 |
| progesterone | decreases expression | EXP | | 6480464 | Progesterone results in decreased expression of TNFSF10 mRNA | CTD | PMID:18070364 |
| quercetin | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with Ascorbic Acid] results in decreased expression of TNFSF10 mRNA | CTD | PMID:17639512 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of TNFSF10 mRNA | CTD | PMID:21632981 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | CTD | PMID:17876056 PMID:18377872 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] | CTD | PMID:18377872 PMID:17876056 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin promotes the reaction [TNFSF10 protein affects the localization of BAX protein]; more ... | CTD | PMID:17876056 |
| quercetin | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with TNFSF10 protein] results in increased expression of ANXA5 protein; more ... | CTD | PMID:18377872 |
| quercetin | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein | CTD | PMID:18980244 |
| quinolin-8-ol | increases expression | EXP | | 6480464 | Oxyquinoline results in increased expression of TNFSF10 mRNA | CTD | PMID:21632981 |
| reserpine | multiple interactions | ISO | RGD:628734 | 6480464 | IAPP protein inhibits the reaction [Reserpine results in increased expression of TNFSF10 protein] | CTD | PMID:19463876 |
| reserpine | increases expression | ISO | RGD:628734 | 6480464 | Reserpine results in increased expression of TNFSF10 protein | CTD | PMID:19463876 |
| resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP2 protein; more ... | CTD | PMID:15763656 |
| resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with TNFSF10 protein] results in increased activity of BAX protein; more ... | CTD | PMID:20097879 |
| resveratrol | increases response to substance | EXP | | 6480464 | resveratrol results in increased susceptibility to TNFSF10 protein | CTD | PMID:20097879 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TNFSF10 protein] | CTD | PMID:21179458 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of TNFSF10 protein | CTD | PMID:21179458 |
| resveratrol | multiple interactions | EXP | | 6480464 | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[resveratrol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein]; more ... | CTD | PMID:18222423 |
| resveratrol | increases response to substance | EXP | | 6480464 | TNFSF10 protein results in increased susceptibility to resveratrol | CTD | PMID:18222423 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP3 protein]; more ... | CTD | PMID:17823925 |
| ribavirin | decreases response to substance | EXP | | 6480464 | Ribavirin results in decreased susceptibility to TNFSF10 protein | CTD | PMID:12637521 |
| riddelliine | increases expression | ISO | RGD:628734 | 6480464 | riddelliine results in increased expression of TNFSF10 mRNA | CTD | PMID:18047727 |
| rifampicin | multiple interactions | ISO | RGD:732827 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of TNFSF10 mRNA | CTD | PMID:21224054 |
| Ro 31-8220 | multiple interactions | EXP | | 6480464 | Ro 31-8220 inhibits the reaction [decitabine results in increased expression of TNFSF10 protein] | CTD | PMID:17283156 |
| Se-methyl-L-selenocysteine | multiple interactions | EXP | | 6480464 | [selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein | CTD | PMID:19360359 |
| Se-methylselenocysteine | multiple interactions | EXP | | 6480464 | [selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein | CTD | PMID:19360359 |
| selenium atom | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of TNFSF10 mRNA | CTD | PMID:19244175 |
| simvastatin | increases response to substance | EXP | | 6480464 | TNFSF10 protein results in increased susceptibility to Simvastatin | CTD | PMID:21910007 |
| simvastatin | multiple interactions | EXP | | 6480464 | geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; more ... | CTD | PMID:21910007 |
| sulindac | increases response to substance | EXP | | 6480464 | Sulindac results in increased susceptibility to TNFSF10 protein | CTD | PMID:21171083 |
| sulindac | multiple interactions | EXP | | 6480464 | [Sulindac co-treated with TNFSF10 protein] results in increased activity of CASP8 protein; more ... | CTD | PMID:21171083 |
| sumatriptan | multiple interactions | ISO | RGD:628734 | 6480464 | Sumatriptan inhibits the reaction [Capsaicin results in increased expression of TNFSF10 protein]; more ... | CTD | PMID:22150557 |
| tamibarotene | increases expression | EXP | | 6480464 | Am 80 results in increased expression of TNFSF10 mRNA; more ... | CTD | PMID:15498508 |
| tamoxifen | multiple interactions | EXP | | 6480464 | [Tamoxifen co-treated with TNFSF10 protein] results in decreased expression of BCL2 protein; more ... | CTD | PMID:17767197 |
| temozolomide | affects response to substance | EXP | | 6480464 | TNFSF10 mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 |
| tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of TNFSF10 mRNA | CTD | PMID:15336504 |
| testosterone enanthate | affects expression | EXP | | 6480464 | testosterone enanthate affects the expression of TNFSF10 mRNA | CTD | PMID:17440010 |
| tetrachloromethane | increases expression | ISO | RGD:732827 | 6480464 | Carbon Tetrachloride results in increased expression of TNFSF10 mRNA; more ... | CTD | PMID:17038628 |
| tetrachloromethane | multiple interactions | ISO | RGD:732827 | 6480464 | copolymer 1 promotes the reaction [Carbon Tetrachloride results in increased expression of TNFSF10 mRNA]; more ... | CTD | PMID:17038628 |
| thalidomide | decreases expression | EXP | | 6480464 | Thalidomide results in decreased expression of TNFSF10 protein | CTD | PMID:16531263 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP2 protein; more ... | CTD | PMID:15763656 |
| trans-resveratrol | increases response to substance | EXP | | 6480464 | resveratrol results in increased susceptibility to TNFSF10 protein | CTD | PMID:20097879 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of TNFSF10 protein] | CTD | PMID:21179458 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with TNFSF10 protein] results in increased activity of BAX protein; more ... | CTD | PMID:20097879 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of TNFSF10 protein | CTD | PMID:21179458 |
| trans-resveratrol | increases response to substance | EXP | | 6480464 | TNFSF10 protein results in increased susceptibility to resveratrol | CTD | PMID:18222423 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[resveratrol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein]; more ... | CTD | PMID:18222423 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP3 protein]; more ... | CTD | PMID:17823925 |
| troglitazone | increases response to substance | EXP | | 6480464 | troglitazone results in increased susceptibility to TNFSF10 protein | CTD | PMID:16820965 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of TNFSF10 mRNA | CTD | PMID:19631733 |
| tunicamycin | decreases expression | ISO | RGD:732827 | 6480464 | Tunicamycin results in decreased expression of TNFSF10 mRNA | CTD | PMID:17127020 |
| valproic acid | multiple interactions | EXP | | 6480464 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[Valproic Acid co-treated with decitabine] results in increased susceptibility to TNFSF10 protein]; more ... | CTD | PMID:21771726 |
| zidovudine | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with IFNA1 protein] results in increased expression of TNFSF10 mRNA | CTD | PMID:20370541 |